Reported about 19 hours ago
Canaccord Genuity has raised its price target for Illumina, Inc. (NASDAQ:ILMN) from $87 to $99 while maintaining a Hold rating. The adjustment follows comments from CEO Jacob Thaysen, who indicated that easing pricing pressures and increased clinical volumes could drive revenue growth. Despite this optimism, Canaccord remains cautious, suggesting that while Illumina has potential, other AI stocks might present better investment opportunities.
Source: YAHOO